Zhang Daoqin, Knutsen Carsten, Stroud David J, Alvira Cristina M
Department of Pediatrics, Division of Critical Care Medicine, University of California San Francisco, San Francisco, CA.
bioRxiv. 2025 Jul 28:2025.07.23.666389. doi: 10.1101/2025.07.23.666389.
After birth, the alveolar capillary network expands to increase gas exchange surface area and endothelial-derived signals promote alveolarization. Lung capillaries are comprised of two distinct subsets, one with proliferative potential to facilitate growth and repair (Cap1), and the other serving a specialized role in gas exchange (Cap2). However, the molecular mechanisms directing capillary speciation, developmental plasticity, and fate transitions during development and repair are not well understood. Here, we show that Cap2 are absent in late embryonic life but rapidly appear and expand immediately after birth. We show that Cap1 progenitors first transition to a novel, intermediate cell state (Cap), characterized by co-expression of Cap1 and Cap2 markers, and heightened proliferation. Cap are present in both the developing mouse and human lung. Hyperoxia, an experimental model of bronchopulmonary dysplasia (BPD), a chronic lung disease marked by impaired alveolarization, increases Cap abundance and persistence and expands Cap2 EC. Cap EC are also increased in human infants dying with active BPD. Using genetic lineage tracing, single cell transcriptomics, ATAC-sequencing and a mouse model that permits inducible deletion of VEGFR2 in Cap and Cap2 EC, we show that postnatal abrogation of VEGFR2 markedly increases Cap EC abundance, blocks Cap2 terminal differentiation, impairs alveolarization, and activates alveolar fibroblasts. Finally, we identify ERG as a putative VEGFR2-downstream mechanism that promotes Cap to Cap2 differentiation. Taken together, our data show that Cap1-Cap2 differentiation is a two-step process that only requires VEGFR2 for the second step. Elucidation of the physiologic and molecular pathways that control the initial transition of Cap1 to Cap EC has the potential to reveal new therapeutic targets for lung diseases that disrupt the alveolar capillary formation and integrity.
出生后,肺泡毛细血管网络扩张以增加气体交换表面积,内皮衍生信号促进肺泡化。肺毛细血管由两个不同的亚群组成,一个具有促进生长和修复的增殖潜力(Cap1),另一个在气体交换中发挥特殊作用(Cap2)。然而,在发育和修复过程中指导毛细血管特化、发育可塑性和命运转变的分子机制尚不清楚。在这里,我们表明Cap2在胚胎后期不存在,但在出生后立即迅速出现并扩张。我们表明Cap1祖细胞首先转变为一种新的中间细胞状态(Cap),其特征是Cap1和Cap2标志物的共表达以及增殖增强。Cap在发育中的小鼠和人类肺中均存在。高氧是支气管肺发育不良(BPD)的一种实验模型,BPD是一种以肺泡化受损为特征的慢性肺病,它会增加Cap丰度和持久性,并扩大Cap2内皮细胞。在患有活动性BPD死亡的人类婴儿中,Cap内皮细胞也会增加。使用遗传谱系追踪、单细胞转录组学、ATAC测序以及一个允许在Cap和Cap2内皮细胞中诱导性缺失VEGFR2的小鼠模型,我们表明出生后VEGFR2的缺失显著增加Cap内皮细胞丰度,阻断Cap2终末分化,损害肺泡化,并激活肺泡成纤维细胞。最后,我们确定ERG是促进Cap向Cap2分化的一种假定的VEGFR2下游机制。综上所述,我们的数据表明Cap1 - Cap2分化是一个两步过程,仅第二步需要VEGFR2。阐明控制Cap1向Cap内皮细胞初始转变的生理和分子途径有可能揭示针对破坏肺泡毛细血管形成和完整性的肺部疾病的新治疗靶点。